An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment. by Gelderblom, H, Perol, D, Chevreau, C, Tattersall, M, Stacchiotti, S, Casali, P, Cropet, C, Piperno-Neumann, S, Le Cesne, A, Italiano, A, Ferraresi, V, Duffaud, F, Penel, N, Dileo, P, Bertucci, F, Hassan, A, Kroep, JR, Denizot-Guillemaut, S, Blay, J

Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study by Mery B, Ménétrier-Caux C, Montané L, Heudel PE, Ray-Coquard I, Bachelot T, Derbel O, Augereau P, Treilleux I, Berthet J, Nkodia A, Bardin-Dit-Courageot C, Attignon V, Ferrari A, Garin G, Perol D, Caux C, Dubois B, Trédan O

Get full text

An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment by Ray-Coquard, I, Gelderblom, H, Chevreau, C, Kroep, JR, Italiano, A, Stacchiotti, S, Le Cesne, A, Piperno-Neumann, S, Ferraresi, V, Duffaud, F, Penel, N, Cassier, P, Tatersall, M, Hassan, A, Nguyen, B, Branchu, V, Guillemaut, S, Cropet, C, Perol, D, Blay, J